In current clinical practice, traditional tumor markers like Cancer Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) play a crucial role in aiding the diagnosis of ovarian cancer and evaluating the effectiveness of tumor treatment. The gene discussed is MUC16; the disease is ovarian carcinoma.